Table of Contents Author Guidelines Submit a Manuscript
Research Article
BioMed Research International
Volume 2018, Article ID 4360219, 1 page
https://doi.org/10.1155/2018/4360219
Erratum

Erratum to “The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China”

1Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
2Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
3Department 2 of Respiratory Medicine, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
4Department of Laboratory Medicine, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
5National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

Correspondence should be addressed to Wenqi Song; moc.361@hcbqwgnos, Yongli Guo; nc.moc.hcb@ilgnoyoug, and Shunying Zhao; moc.anis@codgniynuhsoahz

Received 21 May 2018; Accepted 27 May 2018; Published 6 September 2018

Copyright © 2018 Jie Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Lu, H. Li, F. Dong et al., “The feasibility of xpert MTB/RIF testing to detect rifampicin resistance among childhood tuberculosis for prevalence surveys in Northern China,” BioMed Research International, vol. 2017, Article ID 5857369, 10 pages, 2017. View at Publisher · View at Google Scholar